secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009814
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure reports preliminary Q4 revenue $140.5M (+13%), FY 2025 $534.5M (+15%); guides 2026 revenue ~$600-610M
--------------------------------------------------------------------------------

- Q4 2025 revenue $140.5M (+13% YoY); US $114.3M (+13%), intl $26.2M (+15% as reported).
- FY 2025 revenue $534.5M (+15% YoY); adj. EBITDA $57-59M; adj. loss per share $0.18-0.21.
- Ended 2025 with $167M cash; expects positive cash flow and net income in 2026.
- 2026 revenue guidance $600-610M (+12-14%); adj. EBITDA $80-82M.
- Amended credit facility extended 3 years, reduced interest rate, removed minimum utilization covenant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000119312526009814/0001193125-26-009814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000119312526009814/d43112d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer